Log in or Sign up for Free to view tailored content for your specialty!
Psoriatic Arthritis News
Arthritis among most common chronic conditions for US veterans
Arthritis and hypertension are the two most prevalent chronic conditions among U.S. veterans aged 25 years and older, according to data published by CDC researchers in National Health Statistics Report.
VIDEO: Meeting to address undertreatment of CVD in patients with psoriatic disease
Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania, discusses an upcoming program from the National Heart, Lung, and Blood Institute.
Log in or Sign up for Free to view tailored content for your specialty!
Two-year delay in diagnosis common for patients with psoriatic arthritis
More than half of patients with psoriatic arthritis experience a two-year delay from symptom onset to diagnosis, especially younger patients, those who are obese and those with enthesitis, noted data published in The Journal of Rheumatology.
Heart failure linked to disease activity, inflammation in patients with psoriatic disease
Systemic inflammation burden and disease activity are independent risk factors for heart failure among patients with psoriatic disease, according to data published in Arthritis Care & Research.
Poor cardiorespiratory fitness early in life may predict psoriatic disease in men
Men with poor cardiorespiratory fitness levels during late adolescence were more likely to develop psoriasis or psoriatic arthritis later in life, according to a study.
FDA expands Simponi Aria labeling to include fatigue in RA, PsA
The FDA has approved a label update for Janssen’s golimumab to include language that treatment alongside methotrexate improves fatigue in patients with active psoriatic arthritis and moderately to severely active rheumatoid arthritis.
Ixekizumab effective in psoriatic arthritis up to 1 year regardless of methotrexate use
Ixekizumab is efficacious in patients with psoriatic arthritis for up to 1 year, with or without concomitant methotrexate use, according to data published in Arthritis Research & Therapy.
Moderate, high rheumatic disease activity linked to higher risk for COVID-related death
Moderate and high disease activity, as well as the use of immunosuppressants, were associated with a higher risk for COVID-related death in patients with rheumatic diseases, according to data in the Annals of the Rheumatic Diseases.
'We need to see the data': FDA's Xeljanz safety warning stirs concerns for JAK inhibitors
For Pfizer and its JAK inhibitor, Xeljanz, February rang in with the sound of alarm bells, as the FDA issued its third warning about the drug in 2 years.
Checkpoint inhibitor response, adverse event rate similar regardless of autoimmune disease
Patients’ response to anti-CTLA-4 or anti-PD-1 checkpoint therapy for advanced melanoma, and their incidence of immune-related adverse events of grade 3 or higher, were similar regardless of preexisting autoimmune disease, according to data.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read